Salarius Pharmaceuticals, Inc. (SLRX) Financials
Stock symbol SLRX is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker SLRX was renamed to
DCOY
effective 2026-01-08.
SLRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 8.4 million | 2.3 million |
| June 30, 2023 | 12.1 million | 3.6 million |
| March 31, 2023 | 10.1 million | 4.5 million |
| Dec. 31, 2022 | 14.7 million | 4.3 million |
SLRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -3.7 million | 112658 |
| June 30, 2023 | -4.4 million | 123459 |
| March 31, 2023 | -3.2 million | 203345 |
| Dec. 31, 2022 | -3.2 million | 145507 |
SLRX Net Income
No data available :(
SLRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 7.6 million | - | - |
| June 30, 2023 | 11.5 million | - | - |
| March 31, 2023 | 9.3 million | - | - |
| Dec. 31, 2022 | 12.1 million | - | - |
SLRX Shares Outstanding
SLRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 1.0 million | 1.5 million | - |
| June 30, 2023 | - | 2.4 million | 1.6 million | - |
| March 31, 2023 | - | 3.7 million | 1.7 million | - |
| Dec. 31, 2022 | 1.5 million | 4.7 million | 1.8 million | - |
SLRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 5608 |
| June 30, 2023 | - | 1669 |
| March 31, 2023 | - | 1669 |
| Dec. 31, 2022 | - | 1669 |
SLRX
Price: $0.84
52 week price:
Earnings Per Share: -24.24 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 285400
Market Capitalization: 3.8 million